Teaching Safety

Quote of the Week
"Our motto is to strengthen our strengths and eliminate our weaknesses."
JÜRGEN HAMBRECHT, CHAIRMAN, BASF – p. 10
June 28, 2010
In This Issue:
Jump to Table of Contents ↓
Highlights

Cover Story
Undergrad Lab Safety
Schools are testing programs to more effectively incorporate safety training into students' lab work. (pp. 14-20)

Business
Platinum Drugs Take Their Toll
Small firms struggle to make their compounds the new standard in cancer therapy. (pp. 24-28)

240th ACS National Meeting
Preliminary Program
List of technical symposia and general meeting information for Boston, Aug. 22–26. (pp. 51, 52-64, 69-88)
Table of Contents
Cover Story
Expanding Safety Training pp. 14-20
Schools are exploring a variety of ways to augment laboratory safety instruction for undergraduate students.
Curriculum Resources: A Textbook For Safety p. 17
Personal Protection: Whither Lab Coats? pp. 18-19
News Of The Week
2010 Green Chemistry Awards p. 9
Honors: Presidential challenge awards recognize innovations that promote sustainability.
2010 Presidential Green Chemistry Challenge Awards Web Exclusive
Green Honors: Obama Administration recognizes superlative pollution-prevention technologies.
BASF Inks Bid For Cognis p. 10
Specialties: Latest acquisition will strengthen BASF's position in home and personal care.
EPA Supports Renewal Of Superfund Tax p. 10
Industry Cleanup: Agency urges Congress to pass legislation reinstating tax on chemicals and oil.
Nanostructure Dynamics p. 11
Imaging: time-resolved electron tomography provides 3-D views on ultrafast timescale.
Oil Rig Explosion Probe p. 11
Chemical safety board will investigate the causes of the BP/Deepwater Horizon disaster.
Mylotarg Must Go p. 12
Regulatory Action: The only antibody-drug conjugate on the market has efficacy and safety issues.
Battery Beginnings p. 12
Breaking Ground: Dow venture starts work on lithium-ion battery plant.
New Route To Amide Formation p. 13
Organic Synthesis: Unusual reaction has reactive species with reversed polarities.
Biovail To Buy Valeant p. 13
Complex stock deal valued at about $3.3 billion will create a new firm, Valeant Pharmaceuticals.
Business

Platinum Drugs Take Their Toll pp. 24-28
Small firms struggle to make their compounds the new standard in cancer therapy.
Active Ingredients: Platinum Compounds Are Precious Business Web Exclusive
Collaboration Yielded A New Class Of Cancer Drugs Web Exclusive
Drug Discovery: Academic research institute, metals producer, and a pharmaceutical firm built new platinum compounds on the basis of a serendipitous discovery.
Pedagogy On Platinum Drugs Web Exclusive
Shifting To Services pp. 30-32 (Member Content)
Attendees at Chemspec Europe in Berlin see opportunities in process development and supply-chain management.
Business Concentrates pp. 22-23 (Member Content)
- Chemtura Files Reorganization Plan
- Chemtura has filed a plan of reorganization with the U.S. Bankruptcy Court that is supported by bondholders and other creditors...
- AkzoNobel Sells National Starch
- AkzoNobel is selling National Starch to Corn Products for $1.3 billion in cash plus the assumption of pension and other employee liabilities...
- Fertilizers Planned For South America
- Houston-based engineering firm KBR has received a contract to design and license a 500,000-metric-ton-per-year ammonia plant...
- Soccer Ball Uses Arkema Elastomer
- French chemical firm Arkema’s Pebax Rnew thermoplastic elastomer is being used to make a soccer ball...
- Bristol-Myers Ends Exelixis Pact
- Exelixis has lost another partner for XL184, the most advanced drug candidate in its pipeline...
- Bayer Opens Singapore Lab
- Bayer MaterialScience has opened a functional films research center in Singapore...
- ACC Lowers Outlook For Chemical Growth
- Economists at the American Chemistry Council have moderated their outlook for growth in U.S. chemical output this year...
- J&J And Boehringer Sign Diabetes Deals
- Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit has signed diabetes drug development pacts...
- British Firm Debuts Cannabis Treatment
- GW Pharmaceuticals, in Porton Down, England, has launched Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis...
- Quotient Opens Radiolabeling Lab
- Quotient Bioresearch, a Cambridge, England-based drug development services firm, has opened a radiochemistry facility in Cardiff, England...
- Total Takes Stake In Amyris
- French oil giant Total has taken a 17% stake in industrial biotechnology firm Amyris and will have one representative on the U.S. firm’s board...
- Sanofi And Regulus Sign RNA Pact
- Regulus Therapeutics will work with Sanofi-Aventis to develop drugs based on microRNAs, a class of small noncoding RNAs that regulate gene expression...
- Symyx Rejects One Offer For Another
- Scientific software firm Symyx Technologies has rejected a revised takeover offer from Certara...
- Business Roundup
- Kemira, Dow Chemical, Orica, BASF and RTI International, Huntsman, Bayer Schering Pharma, Pacific Biosciences...
Awards
HHMI Funds Education Advances p. 46 (Member Content)
Rita Colwell Wins Stockholm Water Prize p. 46 (Member Content)
People
Obituaries pp. 48-49 (Member Content)
Government & Policy

Tobacco Turmoil pp. 34-35 (Member Content)
FDA takes first steps to identify hazards in tobacco products and smoke.
Chlorine Shippers Fear Rail Rate Hikes pp. 36-37 (Member Content)
Lobbyists dispute costs, benefits of technology to prevent crashes.
Government & Policy Concentrates p. 33 (Member Content)
- Feds Move To Enforce Chemical Site Security
- The Department of Homeland Security has begun taking action to ensure compliance with the Chemical Facility Anti-Terrorism Standards...
- Administration To Issue New Drilling Ban
- The Obama Administration plans to issue a new order imposing a moratorium on deepwater oil drilling...
- Workers Invited On EPA Inspections
- EPA inspectors will formally invite employees and union representatives to participate in safety checks at...
- NIH Stem Cell Registry Now Has 75 Lines
- NIH Director Francis S. Collins has approved eight more human embryonic stem cell lines, bringing the total...
- Lax Oversight Of Foreign Drug Trials
- FDA should beef up its oversight of clinical drug trials conducted outside the U.S., a report from...
» more government & policy news...
ACS Comment
Patent Reform: Tuning Up America's Innovation Engine p. 44 (Member Content)
ACS Scholars
Karen Martínez-Díaz p. 45
A sister and the ACS Scholars program cemented this chemical sleuth's career path.

Social Networking And C&EN
You can now follow C&EN on Facebook. Become a fan and track the latest news and discussions at facebook.com/CENews.
Science & Technology

The Value Of CO2 pp. 40-41 (Member Content)
Where some see pollution, Andrew Bocarsly sees products.
Green For Eternity pp. 41-42
Start-up companies introduce two routes to stay environmentally friendly after you're dead and gone.
C&EN Talks With John W. Huffman p. 43 (Member Content)
Organic chemist invented a compound in 1995 that is now at the center of a controversy brewing over synthetic marijuana.
Science & Technology Concentrates pp. 38-39 (Member Content)
- Lung On A Chip
- Lung-mimicking device could replace lung cell culture and animal models in drug development and toxicology testing.
- Children’s Blood Has High Levels Of PBDEs
- Kids’ levels of the fire retardants are higher than their mothers’.
- Tweaks Improve Fluorescence Imaging
- Convex lens and a coverslip improve rejection of background fluorescence and increase the achievable observation time.
- Versatile Catalyst Delivers CF3 Groups
- Palladium-mediated method adds influential moiety to a variety of molecules.
- Lithium Cation Isolated Within Fullerene
- Stabilized crystal structure could find use in electronics applications.
- Mechanism Of Suzuki-Miyaura Coupling Revealed
- Surprising findings could help researchers optimize coupling reactions.
- Crystal Growth In Retrospect
- New technique back tracks crystal’s life when in situ methods aren’t workable.
- Electron Emission Delay Is Clue To Dynamics
- Laser experiments reveal 20 attosecond difference between an electron’s ejection time from the 2p orbital versus the 2s orbital.
» more science & technology news...
Meetings
240th ACS National Meeting: Preliminary Program (pp. 51, 52-64, 69-88)
List of technical symposia and general meeting information for Boston, Aug. 22–26.
2010 C&EN Calendar Web Exclusive
C&EN's latest list of meetings and events of interest to those in the chemical community is for June through December.
Editor's Page
Addicted To Growth p. 3
The Departments
Letters pp. 4-6
Newscripts p. 96
Vodka: Analyzed, Filtered, And Poured
C&EN Archives

Now the history of the chemical enterprise is instantly accessible online. C&EN Archives holds the complete collection of C&EN issues dated back from 1923, covering world chemical events, breakthroughs in research, technological advances, business and marketing ventures, government policy, career and education trends, and ACS milestones. With more than 500,000 pages of content, C&EN Archives is instantly accessible and fully searchable, allowing you to discover how the chemical enterprise developed into what it is today.
Head here to discover the past via the C&EN Archives, go to http://pubs.acs.org/cen-archives
CENtral Science
» News, notes, and musings from C&EN
Check out some of the recent posts from C&EN's blog, "C&ENtral Science"
Services & Tools
ACS Resources
ACS Careers
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
» Join ACS
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!